Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Harrison

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungsT W Harrison
BMJ (Clinical Research Ed.)|November 23, 1996
Grand rounds--Nottingham City Hospital. A rare cause of superior vena cava obstructionT W Harrison
Thorax|August 22, 2001
Inhaled steroids for COPD?A E Tattersfield, T W Harrison
Lancet (London, England)|September 23, 1995
Extrathoracic airway dysfunctionT W Harrison, A E Tattersfield
Respiratory Medicine|April 10, 1999
Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthmaT W Harrison, A E Tattersfield
Thorax|March 4, 2003
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjectsT W Harrison, A E Tattersfield
Lancet (London, England)|September 1, 2001
Exacerbations of asthma--still room for improvementA E Tattersfield, T W Harrison
Thorax|August 24, 1999
Step 3 of the asthma guidelinesA E Tattersfield, T W Harrison
Journal of the Royal College of Physicians of London|January 7, 2000
New drugs in asthmaK Phillips, T W Harrison, A Tattersfield
The European Respiratory Journal|March 5, 1999
The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effectsJ A Bennett, T W Harrison, A E Tattersfield
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungsT W Harrison
BMJ (Clinical Research Ed.)|November 23, 1996
Grand rounds--Nottingham City Hospital. A rare cause of superior vena cava obstructionT W Harrison
Thorax|August 22, 2001
Inhaled steroids for COPD?A E Tattersfield, T W Harrison
Lancet (London, England)|September 23, 1995
Extrathoracic airway dysfunctionT W Harrison, A E Tattersfield
Respiratory Medicine|April 10, 1999
Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthmaT W Harrison, A E Tattersfield
Thorax|March 4, 2003
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjectsT W Harrison, A E Tattersfield
Lancet (London, England)|September 1, 2001
Exacerbations of asthma--still room for improvementA E Tattersfield, T W Harrison
Thorax|August 24, 1999
Step 3 of the asthma guidelinesA E Tattersfield, T W Harrison
Journal of the Royal College of Physicians of London|January 7, 2000
New drugs in asthmaK Phillips, T W Harrison, A Tattersfield
The European Respiratory Journal|March 5, 1999
The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effectsJ A Bennett, T W Harrison, A E Tattersfield
Pageof 3